Circulating metabolites are associated with brain atrophy and white matter hyperintensities.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
02 2021
Historique:
received: 16 10 2019
revised: 25 07 2020
accepted: 08 08 2020
pubmed: 5 9 2020
medline: 16 11 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

Our aim was to study whether systemic metabolites are associated with magnetic resonance imaging (MRI) measures of brain and hippocampal atrophy and white matter hyperintensities (WMH). We studied associations of 143 plasma-based metabolites with MRI measures of brain and hippocampal atrophy and WMH in three independent cohorts (n = 3962). We meta-analyzed the results of linear regression analyses to determine the association of metabolites with MRI measures. Higher glucose levels and lower levels of three small high density lipoprotein (HDL) particles were associated with brain atrophy. Higher glucose levels were associated with WMH. Glucose levels were associated with brain atrophy and WMH, and small HDL particle levels were associated with brain atrophy. Circulating metabolites may aid in developing future intervention trials.

Identifiants

pubmed: 32886448
doi: 10.1002/alz.12180
pmc: PMC7984157
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-214

Informations de copyright

© 2020 The Authors. Alzheimer's & Dementia published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.

Références

Eur J Epidemiol. 2007;22(2):99-105
pubmed: 17318336
Lancet Neurol. 2018 May;17(5):434-444
pubmed: 29555425
Circ Cardiovasc Genet. 2015 Feb;8(1):192-206
pubmed: 25691689
Neuroscience. 2014 Jun 13;270:139-47
pubmed: 24735819
Pathology. 2019 Feb;51(2):131-141
pubmed: 30522787
Alzheimers Dement. 2018 Jun;14(6):707-722
pubmed: 29316447
Front Aging Neurosci. 2017 May 09;9:117
pubmed: 28536518
Ann Med. 2005;37(3):173-8
pubmed: 16019715
Nat Med. 2014 Apr;20(4):415-8
pubmed: 24608097
Lancet. 2014 Aug 16;384(9943):607-617
pubmed: 25131980
JAMA Intern Med. 2015 Jul;175(7):1094-1103
pubmed: 25961184
Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):55-63
pubmed: 24248942
Diabetes Care. 2014 Jun;37(6):1689-96
pubmed: 24658392
Ann Neurol. 2016 Jun;79(6):929-39
pubmed: 27016429
J Alzheimers Dis. 2018;62(3):1091-1111
pubmed: 29562540
J Neurosci. 2013 Mar 27;33(13):5553-63
pubmed: 23536070
Neurobiol Dis. 2014 Dec;72 Pt A:22-36
pubmed: 25131449
Nat Rev Neurol. 2010 Feb;6(2):67-77
pubmed: 20139996
Alzheimers Dement. 2018 Jun;14(6):723-733
pubmed: 29519576
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Am J Epidemiol. 2017 Nov 1;186(9):1084-1096
pubmed: 29106475
PLoS One. 2015 Aug 14;10(8):e0135437
pubmed: 26274920
Lancet. 2014 Aug 16;384(9943):618-625
pubmed: 25131981
Eur J Epidemiol. 2017 Sep;32(9):807-850
pubmed: 29064009
Ann Intern Med. 2014 Jan 7;160(1):1-10
pubmed: 24573661
J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1096-8
pubmed: 2292704
J Neurol. 2006 Sep;253(9):1189-96
pubmed: 16998647
Lancet Neurol. 2006 Jan;5(1):64-74
pubmed: 16361024
J Am Coll Cardiol. 2012 Aug 7;60(6):508-16
pubmed: 22796256
Neurology. 2010 Nov 30;75(22):1982-7
pubmed: 21115952
Neurobiol Aging. 2017 Sep;57:186-194
pubmed: 28571653
Analyst. 2009 Sep;134(9):1781-5
pubmed: 19684899
Exp Gerontol. 2013 Dec;48(12):1443-8
pubmed: 24126083
BMC Med. 2015 Jul 21;13:132
pubmed: 26195085
J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1225-33
pubmed: 25872513
Neurobiol Aging. 2008 May;29(5):669-75
pubmed: 17208336
J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):41-4
pubmed: 20667857
Acta Radiol. 2018 Aug;59(8):997-1001
pubmed: 29172642
Int Rev Neurobiol. 2015;122:53-80
pubmed: 26358890
Eur J Epidemiol. 2015 Dec;30(12):1299-315
pubmed: 26650042
Diabetes Care. 2018 Dec;41(12):2535-2543
pubmed: 30327356
Eur Neurol. 1996;36(5):268-72
pubmed: 8864706
Alzheimers Res Ther. 2018 Sep 27;10(1):100
pubmed: 30261928
J Neurol. 1995 Sep;242(9):557-60
pubmed: 8551316
Acta Neuropathol. 2016 May;131(5):645-58
pubmed: 26711459
Alzheimers Dement. 2021 Feb;17(2):205-214
pubmed: 32886448
Trends Mol Med. 2011 Oct;17(10):594-603
pubmed: 21839683
J Neurol Sci. 2016 Jun 15;365:89-95
pubmed: 27206882

Auteurs

Francisca A de Leeuw (FA)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.

Hata Karamujić-Čomić (H)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Betty M Tijms (BM)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.

Carel F W Peeters (CFW)

Department of Epidemiology & Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, The Netherlands.

Maartje I Kester (MI)

Department of Neurology, Flevoziekenhuis, Almere, The Netherlands.

Philip Scheltens (P)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.

Shahzad Ahmad (S)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Dina Vojinovic (D)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Hieab H H Adams (HHH)

Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.

Thomas Hankemeier (T)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Faculty of Science, Leiden University, Leiden, The Netherlands.
Translational Epidemiology, Faculty Science, Leiden University, Leiden, The Netherlands.

Daniel Bos (D)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.

Aad van der Lugt (A)

Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.

Meike W Vernooij (MW)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.

M Arfan Ikram (MA)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Najaf Amin (N)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Frederik Barkhof (F)

Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Institutes of Neurology & Healthcare Engineering, UCL London, London, UK.

Charlotte E Teunissen (CE)

Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.

Cornelia M van Duijn (CM)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Wiesje M van der Flier (WM)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Epidemiology & Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH